GlobeNewswire 2018-07-11 Pulmonary Arterial Hypertension (PAH) Therapeutics 2015-2022 - Global Strategic Business Report 2018
GlobeNewswire 2018-04-10 Global Markets for Contract Pharmaceutical Manufacturing, Research and Packaging 2017-2022 - Market ...
GlobeNewswire 2018-03-21 Vectura Group plc: 2017 Preliminary Results - Performance in-line with expectations, with strong in-...
GlobeNewswire 2018-02-08 Dry Powder Inhalers Market is slated to Exhibit a CAGR of Nearly 4% during the Forecast Period (2017...
GlobeNewswire 2018-01-04 Vectura Group plc: 2017 Pre-close Trading Update and Refocussed Investment Strategy
GlobeNewswire 2017-06-28 Vectura Group plc: New development and licence agreement for a US inhaled generic (VR2081)
GlobeNewswire 2017-06-13 Nanobiotechnology Market 2015-2022 - Global Strategic Business Report 2017: Nanotechnology Revolutio...
GlobeNewswire 2017-04-03 Vectura Group plc: Launch of UtibronTM Neohaler® in the US
GlobeNewswire 2017-01-11 Vectura Group plc: Pre-close update
GlobeNewswire 2016-12-21 Vectura Group plc: Licensing agreement signed for the launch of Utibron/Seebri in the US
GlobeNewswire 2016-08-31 AirFluSal® Forspiro® showed superiority at 12 months over Seretide® Diskus®[1] in persistence to tre...
GlobeNewswire 2008-10-07 New Phase II data on NVA237, a novel once-daily treatment for COPD, show promising efficacy and tole...
GlobeNewswire 2005-04-21 Novartis continues to outpace the market, delivering strong first quarter 2005 sales and earnings gr...